- Home
- Publications
- Publication Search
- Publication Details
Title
Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-18
DOI
10.3389/fphar.2018.00500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P2 receptors in cancer progression and metastatic spreading
- (2016) Francesco Di Virgilio et al. CURRENT OPINION IN PHARMACOLOGY
- Exploiting agonist biased signaling of chemokines to target cancer
- (2016) Ishan Roy et al. MOLECULAR CARCINOGENESIS
- Emerging Roles of P2X Receptors in Cancer
- (2015) Elena Adinolfi et al. CURRENT MEDICINAL CHEMISTRY
- Cholesterol-rich lipid rafts are involved in neuropeptide FF anti-nociceptin/orphanin FQ effect
- (2015) Zhong Ding et al. JOURNAL OF NEUROCHEMISTRY
- Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells
- (2015) Gabriela Schneider et al. Molecular Cancer
- The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
- (2015) F Amoroso et al. ONCOGENE
- Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts
- (2015) Juan Palacios-Moreno et al. PLoS Computational Biology
- Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
- (2014) Anna Lisa Giuliani et al. PLoS One
- The role of kinin receptors in cancer and therapeutic opportunities
- (2013) Patrícia L.N. da Costa et al. CANCER LETTERS
- Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation
- (2013) Ana Pinheiro et al. Cell Communication and Signaling
- Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy
- (2013) Mariusz Z Ratajczak et al. Journal of Ovarian Research
- Expression of P2X7 Receptor Increases In Vivo Tumor Growth
- (2012) E. Adinolfi et al. CANCER RESEARCH
- FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma
- (2012) Michael L. Megison et al. CLINICAL & EXPERIMENTAL METASTASIS
- Focal adhesion kinase overexpression: Correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma
- (2012) Juan Carlos de Vicente et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Interactions between the NO-Citrulline Cycle and Brain-derived Neurotrophic Factor in Differentiation of Neural Stem Cells
- (2012) Claudiana Lameu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinin-B2 Receptor Activity Determines the Differentiation Fate of Neural Stem Cells
- (2012) Cleber A. Trujillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- P2X7 receptor antagonism in the treatment of cancers
- (2011) Sébastien Roger et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness
- (2011) B Jelassi et al. ONCOGENE
- The central nervous system as target for antihypertensive actions of a proline-rich peptide fromBothrops jararacavenom
- (2010) Claudiana Lameu et al. CYTOMETRY PART A
- Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
- (2010) Elena Adinolfi et al. FASEB JOURNAL
- Block of Purinergic P2X7R Inhibits Tumor Growth in a C6 Glioma Brain Tumor Animal Model
- (2010) Jae K. Ryu et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Purinergic regulation of neutrophil chemotaxis
- (2008) W. G. Junger CELLULAR AND MOLECULAR LIFE SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started